Abvc Biopharma (ABVC) Accumulated Expenses (2009 - 2026)
Abvc Biopharma's Accumulated Expenses came in at $4.53 trillion for Q3 2026, up 13.6% from $3.99 trillion a year earlier and up 8.0% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Accumulated Expenses (2009 - 2026) Analysis & Trends
At the end of FY2025, Abvc Biopharma's Accumulated Expenses was $4.16 trillion, up 18.6% from FY2024.
- Accumulated Expenses carries a five-year compound annual growth rate of 1714.0% (FY2020 to FY2025).
- Going back by year, Accumulated Expenses was $3.51 trillion in FY2024, $3.7 million in FY2023 (+27.0%), $2.91 million in FY2022 (+123.7%) and $1.3 million in FY2021 (-38.6%).
- The Q3 2026 figure represents the highest quarterly Accumulated Expenses in data going back to Q2 2009.
- Year-over-year, Accumulated Expenses increased in three of the last four quarters, with growth averaging 9.7%.
- The fastest year-over-year change in Accumulated Expenses over five years came in Q3 2023 (growth of 196.1%), and the weakest in Q1 2022 (a decline of 41.6%).
- Business Quant data shows ABVC's Accumulated Expenses at $4.2 trillion (Q2 2026), $4.15 trillion (Q1 2026) and $4.16 trillion (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4,533.97 Bn |
| Jun 30, 2026 | 4,200.03 Bn |
| Mar 31, 2026 | 4,154.36 Bn |
| Dec 31, 2025 | 4,161.63 Bn |
| Sep 30, 2025 | 3,991.41 Bn |
| Jun 30, 2025 | 4,290.96 Bn |
| Mar 31, 2025 | 3,826.82 Bn |
| Dec 31, 2024 | 3,509.42 Bn |
| Sep 30, 2024 | 3.59 Mn |
| Jun 30, 2024 | 3.63 Mn |
| Mar 31, 2024 | 3.45 Mn |
| Dec 31, 2023 | 3.70 Mn |
| Sep 30, 2023 | 3.56 Mn |
| Jun 30, 2023 | 3.44 Mn |
| Mar 31, 2023 | 2.76 Mn |
| Dec 31, 2022 | 2.91 Mn |
| Sep 30, 2022 | 1.20 Mn |
| Jun 30, 2022 | 1.25 Mn |
| Mar 31, 2022 | 1.25 Mn |
| Dec 31, 2021 | 1.30 Mn |
API Access
Abvc Biopharma Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();